Research of T cell epitope in wheat allergy for developing hydrolyzed food aimed at oral immunotherapy

Research of T cell epitope in wheat allergy for developing hydrolyzed food aimed at oral immunotherapy - Research of T cell epitope in wheat allergy for developing hydrolyzed food aimed at oral immunotherapy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020088

Enrollment

Registered

2015-12-06

Start date

2015-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

wheat allergy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: wheat allergy and control

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
Stimulating whole blood or PBMCs from wheat allergy patients with wheat allergen or peptides to see the reaction of T cell. Compare the T cell epitope with B cell epitope. Compare the T cell response of wheat allergy patients with that of healthy controls.	—

Countries

Japan

Contacts

Public ContactNorio Kawamoto

Gifu University Hospital Department of Pediatrics

noriok-gif@umin.ac.jp058-230-6386

Outcome results